Clinical Trials in Nashville

Showing 4081-4100 of 20,298 trials

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors

NCT06188208

A FIH study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VVD-130850, as single agent and in combination with checkpoint inhibition, in participants with advanced solid and hematologic tumors.

Advanced Solid TumorsAdvanced Hematologic Tumors

Vividion Therapeutics, Inc.125 participantsStarted Jan 2024

Los Angeles, California, United States • Sarasota, Florida, United States • Nashville, Tennessee, United States +17 more locations

COMPLETEDPhase 2< 1 mile

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

NCT05381948

This is a phase 2 randomized, double -masked study comparing the efficacy of EYP-1901 at 2 dose levels: 2060 microgram (mcg) and 3090 mcg against aflibercept.

Wet Age-related Macular Degeneration

EyePoint Pharmaceuticals, Inc.161 participantsStarted Jun 2022

Phoenix, Arizona, United States • Springdale, Arkansas, United States • Beverly Hills, California, United States +64 more locations

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

Find Trials by Condition in Nashville

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

CemiplimAb Survivorship Epidemiology

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Longitudinal Study of Mitochondrial Hepatopathies

Biliary Atresia Study in Infants and Children

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)

A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer

Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC